Skip to main content

Corriente Advisors, LLC

SEC CIK
0001406718
Latest filing
Feb 14, 2024

Holdings in Q2 2021

Holdings as of Jun 30, 2021, filed Aug 16, 2021. Long positions only; changes compare share counts with Q1 2021.

Institution overview
Positions
15
+5 vs. Q1 2021
Portfolio value
$185.4M
−$86.2M (−31.7%) vs. Q1 2021
Filed
Aug 16, 2021
SEC
Holdings of Corriente Advisors, LLC in Q2 2021
SecurityClassSharesValue% of portfolioShare changeActionHistory
MAXRMaxar Technologies Inc.COM1,920,333$76.7M41.3%−729,667−27.5%ReducedHistory
CUECue Biopharma, Inc.COM1,486,986$17.3M9.3%−1,062,045−41.7%ReducedHistory
REPLReplimune Group, Inc.COM449,879$17.3M9.3%−625,121−58.2%ReducedHistory
COINCoinbase Global, Inc.COM CL A40,000$10.1M5.5%+40,000NewHistory
RETAReata Pharmaceuticals IncCL A71,115$10.1M5.4%+71,115NewHistory
QSQuantumScape CorpCOM CL A337,316$9.87M5.3%+337,316NewHistory
LTRNLantern Pharma Inc.COM656,364$9.58M5.2%−57,442−8.0%ReducedHistory
CRDFCardiff Oncology, Inc.COM1,383,500$9.20M5.0%−1,401,910−50.3%ReducedHistory
KTOSKratos Defense & Security Solutions, Inc.COM NEW275,738$7.86M4.2%+275,738NewHistory
MPMP Materials Corp.COM CL A110,000$4.05M2.2%+110,000NewHistory
HIMXHimax Technologies, Inc.SPONSORED ADR200,000$3.33M1.8%+200,000NewHistory
CRSPCRISPR Therapeutics AGNAMEN AKT20,000$3.24M1.7%+20,000NewHistory
IRDMIridium Communications Inc.COM80,000$3.20M1.7%+80,000NewHistory
RBLXRoblox CorpStock30,000$2.70M1.5%+30,000NewHistory
DMACDiaMedica Therapeutics Inc.COM NEW203,641$906.0K0.5%−666,587−76.6%ReducedHistory

Sold out since Q1 2021 (4)

Positions held at the end of Q1 2021 that are gone from this filing.

Positions of Corriente Advisors, LLC sold out since Q1 2021
SecurityClassShares in Q1 2021Value in Q1 2021% of portfolio in Q1 2021History
TDYTeledyne Technologies IncCOM55,000$22.8M8.4%History
TFFPTFF Pharmaceuticals, Inc.COM1,565,682$21.2M7.8%History
METAMeta Platforms, Inc.Stock50,000$14.7M5.4%History
EYPTEyePoint, Inc.COM NEW200,000$2.03M0.7%History